Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × tesetaxel × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 2 Neoplasms 1

Interventions

pembrolizumab 35 Nivolumab 19 trametinib 13 Cyclophosphamide 13 dabrafenib 10 Interleukin-2 10 Vemurafenib 8 fludarabine 7 Ipilimumab 7 Docetaxel 7 Paclitaxel 6 Cisplatin 6 Carboplatin 6 fludarabine phosphate 5 cemiplimab 5 Radiotherapy 5 Dacarbazine 5 Blood Specimen Collection 5 Biopsy 5 binimetinib 4 atezolizumab 4 Therapeutics 4 Drug Therapy 4 sotigalimab 3 poly ICLC 3 montanide ISA 51 3 encorafenib 3 cobimetinib 3 budigalimab 3 aldesleukin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01064713 2018-07-17

Phase II Study of Tesetaxel in Metastatic Melanoma

M.D. Anderson Cancer Center

Phase 2 Completed

17 enrolled 5 charts

Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡